We reveal that reduced FADD levels are associated with poor prognosis in precursor T-cell neoplasms, and that such reductions determined a significant enrichment of oncogenic gene signatures, including resistance to chemotherapy. Here, FADD is linked to T-cell and NK-cell neoplasm.